nodes	percent_of_prediction	percent_of_DWPC	metapath
Gamma Hydroxybutyric Acid—SLC16A1—Methotrexate—testicular cancer	0.323	1	CbGbCtD
Gamma Hydroxybutyric Acid—SLC52A2—embryo—testicular cancer	0.0291	0.162	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—seminal vesicle—testicular cancer	0.0273	0.152	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—female gonad—testicular cancer	0.016	0.0891	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—testis—testicular cancer	0.0142	0.079	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—gonad—testicular cancer	0.0118	0.0654	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—gonad—testicular cancer	0.0112	0.0624	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—lymph node—testicular cancer	0.0103	0.0573	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—female gonad—testicular cancer	0.00957	0.0531	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—testis—testicular cancer	0.00849	0.0471	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—testis—testicular cancer	0.0081	0.045	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—gonad—testicular cancer	0.00715	0.0397	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—lymph node—testicular cancer	0.00615	0.0342	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—lymph node—testicular cancer	0.00587	0.0326	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—female gonad—testicular cancer	0.00581	0.0323	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—testis—testicular cancer	0.00516	0.0286	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—lymph node—testicular cancer	0.00374	0.0208	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00203	0.256	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00161	0.202	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000923	0.116	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000867	0.109	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00073	0.092	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Feeling abnormal—Cisplatin—testicular cancer	0.00053	0.00108	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Etoposide—testicular cancer	0.000529	0.00108	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight increased—Epirubicin—testicular cancer	0.000529	0.00108	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Methotrexate—testicular cancer	0.000528	0.00108	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight decreased—Epirubicin—testicular cancer	0.000526	0.00107	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Etoposide—testicular cancer	0.000526	0.00107	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Epirubicin—testicular cancer	0.000524	0.00107	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Etoposide—testicular cancer	0.000524	0.00107	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Methotrexate—testicular cancer	0.000522	0.00107	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Bleomycin—testicular cancer	0.000519	0.00106	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Epirubicin—testicular cancer	0.000518	0.00106	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Epirubicin—testicular cancer	0.000518	0.00106	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Dactinomycin—testicular cancer	0.000518	0.00106	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Dactinomycin—testicular cancer	0.000514	0.00105	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Etoposide—testicular cancer	0.000513	0.00105	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Ifosfamide—testicular cancer	0.000511	0.00104	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Etoposide—testicular cancer	0.000509	0.00104	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Etoposide—testicular cancer	0.000508	0.00104	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Epirubicin—testicular cancer	0.000505	0.00103	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Etoposide—testicular cancer	0.000504	0.00103	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Etoposide—testicular cancer	0.000504	0.00103	CcSEcCtD
Gamma Hydroxybutyric Acid—Pollakiuria—Doxorubicin—testicular cancer	0.000497	0.00102	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Epirubicin—testicular cancer	0.000494	0.00101	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Ifosfamide—testicular cancer	0.000494	0.00101	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Methotrexate—testicular cancer	0.000493	0.00101	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Methotrexate—testicular cancer	0.000491	0.001	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight increased—Doxorubicin—testicular cancer	0.000489	0.001	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Epirubicin—testicular cancer	0.000489	0.000999	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Methotrexate—testicular cancer	0.000487	0.000996	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight decreased—Doxorubicin—testicular cancer	0.000487	0.000995	CcSEcCtD
Gamma Hydroxybutyric Acid—Sinusitis—Epirubicin—testicular cancer	0.000486	0.000994	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Etoposide—testicular cancer	0.000486	0.000993	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Doxorubicin—testicular cancer	0.000485	0.000992	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Dactinomycin—testicular cancer	0.000484	0.000989	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Etoposide—testicular cancer	0.000482	0.000986	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Doxorubicin—testicular cancer	0.00048	0.00098	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Doxorubicin—testicular cancer	0.00048	0.00098	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Ifosfamide—testicular cancer	0.000475	0.00097	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Cisplatin—testicular cancer	0.000474	0.000969	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Ifosfamide—testicular cancer	0.000471	0.000962	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Ifosfamide—testicular cancer	0.00047	0.000961	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000469	0.0591	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Urticaria—Etoposide—testicular cancer	0.000468	0.000958	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Doxorubicin—testicular cancer	0.000467	0.000956	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Epirubicin—testicular cancer	0.000466	0.000953	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Etoposide—testicular cancer	0.000466	0.000953	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Methotrexate—testicular cancer	0.000465	0.00095	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Methotrexate—testicular cancer	0.000463	0.000948	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Epirubicin—testicular cancer	0.000463	0.000946	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Cisplatin—testicular cancer	0.000462	0.000944	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Epirubicin—testicular cancer	0.000462	0.000944	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Methotrexate—testicular cancer	0.000461	0.000943	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Epirubicin—testicular cancer	0.000459	0.000939	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Epirubicin—testicular cancer	0.000458	0.000937	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Doxorubicin—testicular cancer	0.000457	0.000935	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Epirubicin—testicular cancer	0.000457	0.000935	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Epirubicin—testicular cancer	0.000456	0.000932	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Doxorubicin—testicular cancer	0.000452	0.000925	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Methotrexate—testicular cancer	0.000451	0.000922	CcSEcCtD
Gamma Hydroxybutyric Acid—Sinusitis—Doxorubicin—testicular cancer	0.00045	0.00092	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Methotrexate—testicular cancer	0.000449	0.000918	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Methotrexate—testicular cancer	0.000448	0.000916	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Methotrexate—testicular cancer	0.000446	0.000912	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Ifosfamide—testicular cancer	0.000443	0.000907	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Cisplatin—testicular cancer	0.00044	0.0009	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Methotrexate—testicular cancer	0.000439	0.000898	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Methotrexate—testicular cancer	0.000436	0.00089	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Epirubicin—testicular cancer	0.000435	0.000889	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Etoposide—testicular cancer	0.000434	0.000888	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Epirubicin—testicular cancer	0.000434	0.000887	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Methotrexate—testicular cancer	0.000433	0.000885	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Epirubicin—testicular cancer	0.000432	0.000883	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Doxorubicin—testicular cancer	0.000432	0.000882	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Doxorubicin—testicular cancer	0.000428	0.000876	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Doxorubicin—testicular cancer	0.000427	0.000873	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Doxorubicin—testicular cancer	0.000425	0.000869	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Doxorubicin—testicular cancer	0.000424	0.000867	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Methotrexate—testicular cancer	0.000424	0.000866	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Etoposide—testicular cancer	0.000423	0.000865	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Doxorubicin—testicular cancer	0.000423	0.000865	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Epirubicin—testicular cancer	0.000422	0.000863	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Doxorubicin—testicular cancer	0.000422	0.000863	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Epirubicin—testicular cancer	0.00042	0.000859	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Epirubicin—testicular cancer	0.000419	0.000857	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Methotrexate—testicular cancer	0.000419	0.000856	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Epirubicin—testicular cancer	0.000417	0.000853	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Epirubicin—testicular cancer	0.000411	0.00084	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Cisplatin—testicular cancer	0.000409	0.000837	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Methotrexate—testicular cancer	0.000408	0.000834	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Epirubicin—testicular cancer	0.000408	0.000833	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Cisplatin—testicular cancer	0.000406	0.00083	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Cisplatin—testicular cancer	0.000405	0.000829	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Epirubicin—testicular cancer	0.000405	0.000828	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Etoposide—testicular cancer	0.000403	0.000825	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Doxorubicin—testicular cancer	0.000402	0.000822	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Doxorubicin—testicular cancer	0.000401	0.00082	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Methotrexate—testicular cancer	0.0004	0.000818	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Doxorubicin—testicular cancer	0.0004	0.000817	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Epirubicin—testicular cancer	0.000397	0.000812	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Epirubicin—testicular cancer	0.000397	0.000811	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000394	0.0497	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nervousness—Epirubicin—testicular cancer	0.000393	0.000804	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Epirubicin—testicular cancer	0.000392	0.000801	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Doxorubicin—testicular cancer	0.000391	0.000798	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Etoposide—testicular cancer	0.00039	0.000797	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Epirubicin—testicular cancer	0.000389	0.000796	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Doxorubicin—testicular cancer	0.000389	0.000795	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Methotrexate—testicular cancer	0.000389	0.000795	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Doxorubicin—testicular cancer	0.000388	0.000793	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Doxorubicin—testicular cancer	0.000386	0.00079	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Cisplatin—testicular cancer	0.000382	0.000782	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Epirubicin—testicular cancer	0.000382	0.00078	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Doxorubicin—testicular cancer	0.00038	0.000778	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Doxorubicin—testicular cancer	0.000377	0.000771	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Methotrexate—testicular cancer	0.000375	0.000767	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Etoposide—testicular cancer	0.000375	0.000766	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Doxorubicin—testicular cancer	0.000375	0.000766	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Epirubicin—testicular cancer	0.000374	0.000765	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Epirubicin—testicular cancer	0.000372	0.000761	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Etoposide—testicular cancer	0.000372	0.00076	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Etoposide—testicular cancer	0.000371	0.000759	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000371	0.0467	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Etoposide—testicular cancer	0.000369	0.000755	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Methotrexate—testicular cancer	0.000368	0.000753	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Methotrexate—testicular cancer	0.000368	0.000753	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Methotrexate—testicular cancer	0.000368	0.000753	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Doxorubicin—testicular cancer	0.000368	0.000752	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Doxorubicin—testicular cancer	0.000367	0.00075	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000366	0.000748	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervousness—Doxorubicin—testicular cancer	0.000364	0.000744	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Epirubicin—testicular cancer	0.000364	0.000744	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Epirubicin—testicular cancer	0.000363	0.000742	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Doxorubicin—testicular cancer	0.000362	0.000741	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Doxorubicin—testicular cancer	0.00036	0.000736	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Epirubicin—testicular cancer	0.000358	0.000732	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Methotrexate—testicular cancer	0.000356	0.000728	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Epirubicin—testicular cancer	0.000356	0.000728	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Doxorubicin—testicular cancer	0.000353	0.000722	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Epirubicin—testicular cancer	0.000351	0.000717	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Methotrexate—testicular cancer	0.000351	0.000717	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Etoposide—testicular cancer	0.00035	0.000716	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Epirubicin—testicular cancer	0.00035	0.000715	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Methotrexate—testicular cancer	0.000346	0.000708	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Doxorubicin—testicular cancer	0.000346	0.000708	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Epirubicin—testicular cancer	0.000345	0.000705	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Epirubicin—testicular cancer	0.000345	0.000705	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Epirubicin—testicular cancer	0.000345	0.000705	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Doxorubicin—testicular cancer	0.000344	0.000704	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Epirubicin—testicular cancer	0.000344	0.000702	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Methotrexate—testicular cancer	0.000343	0.000701	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000342	0.0007	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Methotrexate—testicular cancer	0.000341	0.000698	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Epirubicin—testicular cancer	0.000337	0.000689	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Doxorubicin—testicular cancer	0.000337	0.000688	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Methotrexate—testicular cancer	0.000337	0.000688	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Doxorubicin—testicular cancer	0.000336	0.000687	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Epirubicin—testicular cancer	0.000333	0.000681	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Doxorubicin—testicular cancer	0.000331	0.000677	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Epirubicin—testicular cancer	0.000331	0.000676	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Doxorubicin—testicular cancer	0.000329	0.000673	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Epirubicin—testicular cancer	0.000328	0.000671	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Epirubicin—testicular cancer	0.000325	0.000665	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Doxorubicin—testicular cancer	0.000325	0.000664	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Epirubicin—testicular cancer	0.000324	0.000663	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Doxorubicin—testicular cancer	0.000324	0.000661	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000322	0.000658	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Epirubicin—testicular cancer	0.000321	0.000656	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Epirubicin—testicular cancer	0.00032	0.000653	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Methotrexate—testicular cancer	0.000319	0.000653	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Doxorubicin—testicular cancer	0.000319	0.000652	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Doxorubicin—testicular cancer	0.000319	0.000652	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Doxorubicin—testicular cancer	0.000319	0.000652	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Doxorubicin—testicular cancer	0.000318	0.00065	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Methotrexate—testicular cancer	0.000317	0.000648	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000317	0.000648	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Epirubicin—testicular cancer	0.000315	0.000644	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Methotrexate—testicular cancer	0.000315	0.000644	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Methotrexate—testicular cancer	0.000314	0.000642	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Doxorubicin—testicular cancer	0.000312	0.000638	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Methotrexate—testicular cancer	0.000311	0.000636	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Doxorubicin—testicular cancer	0.000308	0.00063	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Methotrexate—testicular cancer	0.000307	0.000628	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Doxorubicin—testicular cancer	0.000306	0.000625	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000305	0.000623	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Methotrexate—testicular cancer	0.000304	0.000622	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Doxorubicin—testicular cancer	0.000304	0.000621	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Methotrexate—testicular cancer	0.000302	0.000617	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000301	0.000616	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Doxorubicin—testicular cancer	0.000301	0.000615	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Doxorubicin—testicular cancer	0.0003	0.000613	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Epirubicin—testicular cancer	0.000299	0.000611	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Doxorubicin—testicular cancer	0.000297	0.000607	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Epirubicin—testicular cancer	0.000297	0.000607	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Doxorubicin—testicular cancer	0.000296	0.000604	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Epirubicin—testicular cancer	0.000295	0.000602	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Epirubicin—testicular cancer	0.000294	0.000601	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Doxorubicin—testicular cancer	0.000292	0.000596	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Methotrexate—testicular cancer	0.000291	0.000595	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Epirubicin—testicular cancer	0.000291	0.000595	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Methotrexate—testicular cancer	0.000289	0.00059	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Epirubicin—testicular cancer	0.000287	0.000587	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000285	0.000583	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Epirubicin—testicular cancer	0.000285	0.000583	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Epirubicin—testicular cancer	0.000283	0.000578	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Epirubicin—testicular cancer	0.000283	0.000578	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Methotrexate—testicular cancer	0.000281	0.000574	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Methotrexate—testicular cancer	0.000279	0.000571	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000279	0.00057	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Doxorubicin—testicular cancer	0.000277	0.000565	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Doxorubicin—testicular cancer	0.000275	0.000561	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Doxorubicin—testicular cancer	0.000273	0.000557	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Epirubicin—testicular cancer	0.000272	0.000557	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Doxorubicin—testicular cancer	0.000272	0.000556	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Epirubicin—testicular cancer	0.00027	0.000553	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Doxorubicin—testicular cancer	0.000269	0.00055	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Doxorubicin—testicular cancer	0.000266	0.000543	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000264	0.00054	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Doxorubicin—testicular cancer	0.000264	0.000539	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Epirubicin—testicular cancer	0.000263	0.000537	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Doxorubicin—testicular cancer	0.000262	0.000535	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Doxorubicin—testicular cancer	0.000262	0.000535	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Epirubicin—testicular cancer	0.000261	0.000534	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Methotrexate—testicular cancer	0.00026	0.000532	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Methotrexate—testicular cancer	0.000253	0.000518	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Doxorubicin—testicular cancer	0.000252	0.000515	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00025	0.000511	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Epirubicin—testicular cancer	0.000244	0.000498	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Doxorubicin—testicular cancer	0.000243	0.000497	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Doxorubicin—testicular cancer	0.000242	0.000494	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Methotrexate—testicular cancer	0.000242	0.000494	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Epirubicin—testicular cancer	0.000237	0.000485	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Methotrexate—testicular cancer	0.000234	0.000477	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Epirubicin—testicular cancer	0.000226	0.000462	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Doxorubicin—testicular cancer	0.000225	0.000461	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Methotrexate—testicular cancer	0.000225	0.000459	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Methotrexate—testicular cancer	0.000223	0.000455	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Methotrexate—testicular cancer	0.000222	0.000455	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Methotrexate—testicular cancer	0.000221	0.000452	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Doxorubicin—testicular cancer	0.000219	0.000449	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Epirubicin—testicular cancer	0.000219	0.000447	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Epirubicin—testicular cancer	0.00021	0.00043	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Methotrexate—testicular cancer	0.00021	0.000429	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Doxorubicin—testicular cancer	0.000209	0.000428	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Epirubicin—testicular cancer	0.000208	0.000426	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Epirubicin—testicular cancer	0.000208	0.000426	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Epirubicin—testicular cancer	0.000207	0.000423	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Doxorubicin—testicular cancer	0.000202	0.000413	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.0002	0.0252	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Epirubicin—testicular cancer	0.000196	0.000401	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Doxorubicin—testicular cancer	0.000194	0.000398	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Doxorubicin—testicular cancer	0.000193	0.000394	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Doxorubicin—testicular cancer	0.000193	0.000394	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Doxorubicin—testicular cancer	0.000192	0.000392	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Doxorubicin—testicular cancer	0.000182	0.000371	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000173	0.0218	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HPGDS—testicular cancer	6.3e-05	0.00795	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—STK11—testicular cancer	4.58e-05	0.00577	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HPGDS—testicular cancer	3.4e-05	0.00429	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—STK11—testicular cancer	2.47e-05	0.00312	CbGpPWpGaD
